Rise Advisors’s Korro Bio KRRO Stock Holding History

Rise Advisors’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-29	Closed	-$362	–	1576
2025 Q2	$362	Buy	+29	New	+$418	﹤0.01%	1458

Other funds holding KRRO

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Rise Advisors's KRRO Position: Q3 2025 in Review

Rise Advisors sold out of Korro Bio (KRRO) in Q3 2025, closing a stake of 29 shares — an estimated $362 sold.

Rise Advisors first reported a position in KRRO in Q2 2025 and held it in 1 quarter. The position peaked at $362 in Q2 2025. 92 funds tracked by Wall St. Rank hold KRRO as of Q3 2025.

Rise Advisors reported no remaining Korro Bio position as of Q3 2025 after selling out during the quarter.
Rise Advisors sold 29 Korro Bio shares in Q3 2025, an estimated $362.
Rise Advisors first reported a position in Korro Bio in Q2 2025 and held it in 1 quarter.
Rise Advisors's Korro Bio position peaked at $362 in Q2 2025.
92 funds tracked by Wall St. Rank held Korro Bio as of Q3 2025.

Based on Rise Advisors's 13F filing for Q3 2025, filed 8 Oct 2025.